Followers | 128 |
Posts | 5486 |
Boards Moderated | 0 |
Alias Born | 06/09/2020 |
Friday, March 18, 2022 8:06:28 AM
Is is wise to raise?
Is it wise to direct peoples attention towards a treatment, that for almost 25 years now, have shown extreme efficacy towards the most extreme of cancers and which now seems to be "last man standing" in a historical race to remove Stupp from the SOC throne?
Someone mentioned 450 failed trials "along the way" and here we have DCvax-L and a history of harassment from a quite astounding "opposition group" and obstacles of rules and regulations for getting to the endgoal, that somehow NWBO managed to manoeuvre themselves around and sometimes the obstacles removed themselves. WHO changing tumors classification. FDA changing their draft guide and publishing articles green lighting external control arms.
So when this "opposition group" nags about waiting and delay and really seems to care for patients, then perhaps they ought to ask themselves, why is it DCVax-L that now stands at the endgoal and not a success from the 450 trials before?
What did NWBO do better and different?
And the keywords are indeed better and different!!!
And taking their time, somehow not only got them to data lock, to certification of manufactoring, to having built out Sawston to now encompass 40 people ready for commercial demand, to buy an automation system and better it, to be able to automate and 10 fold increase doses.
Why are people not battering the 450 failed trials for failing.
WHY DID YOU FAIL? PATIENTS NEEDED YOU!!! PATIENTS HAVE DIED!!!
When DCvax-L has been approved, it will INDEED be time to reflect about the past and the WHY'S!
Why should it take so many years?
Why did NWBO have to make decisions, that kicked the can down the road?
Did they FEEL they HAD to?
And what if they HADN'T? Would DCVAX-L have been number 451?
I hope we all somehow get that knowledge. What happened those years behind the curtains?
Until then, is this anniversary a wise topic to raise?
Anyone on this forum ought not to ask, but to know the answer to that question.
Well done Linda's and co.
Recent NWBO News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/03/2024 08:01:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 08:01:24 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2024 09:06:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2024 08:30:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 02:42:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/30/2024 11:49:38 PM
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
SANUWAVE Announces Reverse Stock Split, Note and Warrant Exchange, and PIPE Offering • SNWV • Oct 18, 2024 9:31 AM
Vocodia Addresses Recent Stock Price Movement and Future Strategic Partnerships • VHAI • Oct 18, 2024 9:00 AM
Mass Megawatts Announces the Start of an Online Discount Solar Energy Equipment Business with Revenue Recognized for the First Time Since Year 2010 in this Fiscal Quarter • MMMW • Oct 18, 2024 7:32 AM
Unitronix Corp Advances DeFi Innovation with Tokenized Real-World Assets Integration • UTRX • Oct 17, 2024 7:38 AM
Mass Megawatts Commences Solar Energy Sales Efforts • MMMW • Oct 16, 2024 7:45 AM
SANUWAVE Health Announces 1-For-375 Reverse Stock Split • SNWV • Oct 16, 2024 7:40 AM